ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................JBDM Ver 2.0.24 - 2999001/03650019CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120231011W173deBibliographieenBibliographyfrBibliographieEP19214674.4201505272019121020220623enenenPCT/EP2015/06176520150527WO201462003764 P20140528US201462004304 P20140529US201462042506 P20140827US2023101120234120200513202020202309062023362023033120231011202341A61K 31/138 20060101AFI20200406BHEP A61K 31/439 20060101ALI20200406BHEP A61K 31/58 20060101ALI20200406BHEP A61P 11/06 20060101ALI20200406BHEP A61P 11/00 20060101ALI20200406BHEP A61K 9/00 20060101ALI20200406BHEP A61K 31/58 20130101 LI20150728BHEP A61K2300/00 20130101 LI20150728BHEP A61K 31/439 20130101 LI20150728BHEP A61K2300/00 20130101 LI20150728BHEP A61K 31/138 20130101 LI20150728BHEP A61K2300/00 20130101 LI20150728BHEP A61K 31/138 20130101 LI20150728BHEP A61K 31/439 20130101 LI20150728BHEP A61K 31/58 20130101 FI20150728BHEP A61P 11/00 20180101 LI20200318BHEP A61P 11/06 20180101 LI20200318BHEP A61P 43/00 20180101 LI20200331BHEP A61K 9/0075 20130101 LI20200402BHEP deFLUTICASONFUROAT BEI DER BEHANDLUNG VON COPDenFLUTICASONE FUROATE IN THE TREATMENT OF COPDfrFUROATE DE FLUTICASONE UTILISÉ DANS LE TRAITEMENT DE LA BPCOWO-A1-2011/067212MONA BAFADHEL ET AL: "Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 186, no. 1, 1 July 2012 (2012-07-01), pages 48-55, XP055204840, ISSN: 1073-449X, DOI: 10.1164/rccm.201108-1553OCPASCOE STEVEN ET AL: "Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.", THE LANCET. RESPIRATORY MEDICINE JUN 2015, vol. 3, no. 6, 13 April 2015 (2015-04-13), pages 435-442, XP008177095, ISSN: 2213-2619NEIL C. BARNES ET AL: "Blood eosinophils as a marker of response to inhaled corticosteroids in COPD", EUROPEAN RESPIRATORY JOURNAL, vol. 47, no. 5, 25 February 2016 (2016-02-25), pages 1374-1382, XP055522832, GB ISSN: 0903-1936, DOI: 10.1183/13993003.01370-201515726106.631485212015052723191900.2425274220230817BARNES, Neil ChristopherGlaxoSmithKline Unit 1A Horton RoadUxbridge, Middlesex UB7 8JJGBPASCOE, Steven JohnGlaxoSmithKline 5 Moore DriveResearch Triangle Park, North Carolina 27709USGlaxoSmithKline Intellectual Property Development Limited102002610PB65702D1 EPGSK Medicines Research Centre Gunnels Wood RoadStevenage SG1 2NYGBFowler, Gavin James101307758GlaxoSmithKline Global Patents (CN925.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20191210ME20191210